Skip to main content
. 2020 Dec 22;14(2):100987. doi: 10.1016/j.tranon.2020.100987

Fig. 4.

Fig. 4

β-catenin overexpression decreases sensitivity to a PARPi or cisplatin in ovarian cancer cells.

HeyA8 and SKOV3 cells were transfected with either β-catenin without the 3′-UTR or EV. Cell viability was assessed by CCK8 assay (A–D) and clonogenic cell-survival assay (E,F).